Department of Pathology

Gerard Lozanski, MD

Professor

Gerard Lozanski, MD

Phone:

614-293-4331

E-mail:

Email Dr. Lozanski

Mailing Address:

310 Doan Hall
410 W. 10th Ave
Columbus, OH 43210

Biosketch

Gerard Lozanski, MD is a Professor in the Clinical Pathology Branch. He is also the Director of the Clinical Flow Cytometry Laboratory at OSUMC. Dr. Lozanski earned his MD from the Karol Marcinkowski Medical Academy in Poznan, Poland. He completed a residency in Anatomic and Clinical Pathology at the Akron City Hospital in Akron, Ohio followed by a fellowship in Hematopathology at the Cleveland Clinic Foundation. Dr. Lozanski is board certified in Anatomic and Clinical Pathology and Hematopathology.

Board Certifications

Special Qualification in Hematopathology: American Board of Pathology

Anatomic and Clinical Pathology: American Board of Pathology

Academic and Medical Appointments

2016-Present Professor of Pathology Clinical, Department of Pathology, The Ohio State University, Columbus, OH

2011-2016 Associate Professor of Pathology Clinical, Department of Pathology, The Ohio State University, Columbus, OH

2002-2011 Assistant Professor of Pathology Clinical, Department of Pathology, The Ohio State University, Columbus, OH

Director, Hematopathology Division, The Ohio State University Wexner Medical Center, Columbus, OH

Director, Hematopathology Fellowship, The Ohio State University Wexner Medical Center, Columbus, OH

Director, Flow Cytometry Lab, The Ohio State University Wexner Medical Center, Columbus, OH

Education and Training

2001-2002 Fellow, Hematopathology, The Cleveland Clinic Foundation, Cleveland, OH

1996-2001 Resident, Anatomic and Clinical Pathology, Akron City Hospital, Akron, OH

1987-1990 Resident, Obstetrics and Gynecology, Medical Academy, Poznan, Poland

Selected Publications

Search in PubMed

Books:

  • Grever MR, Lozanski G. Hairy Cell Leukemia, chapter 93. Williams Hematology 9th edition. McGraw-Hill Professional. 2014.
  • Hemminger J.A. and Lozanski G. 2014. Molecular Pathology of Chronic Lymphocytic Leukemia and Relevance to Novel Therapies. In: Linda M. McManus, Richard N. Mitchell, editors. Pathobiology of Human Disease. San Diego: Elsevier; 2014. p. 1664-1676.
  • Grever MR, Andritsos LA, Lozanski G. 2008. Chronic lymphoid leukemias. In Clinical Oncology. Fourth ed. Edited by Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG. New York, NY, USA: Churchill Livingstone.
  • Blum KA, Lozanski G, Byrd JC. 2006. Adult Burkitt leukemia and lymphoma. In The Lymphomas. Second ed. Edited by Canellos G, Andrew T, Young B. New York, NY, USA: Elsevier. 280-294.
  • Wiktorowicz K, Lozanski G, Pawlowski T, Kapcinska M, Mackiewicz S. 1988. Effect of acute on lectin-induced lymphocyte proliferation. In Lectins Biology and Biochemistry. Edited by Freed D, Bog-Hansen TC. St. Louis, Missouri, USA: Sigma Press.

Publications:

  • Grever MR, Abdel-Wahab O, Andritsos LA, Banerji V, Barrientos J, Blachly JS, Call TG, Catovsky D, Dearden C, Demeter J, Else M, Forconi F, Gozzetti A, Ho AD, Johnston JB, Jones J, Juliusson G, Kraut E, Kreitman RJ, Larratt L, Lauria F, Lozanski G, Montserrat E, Parikh SA, Park JH, Polliack A, Quest GR, Rai KR, Ravandi F, Robak T, Saven A, Seymour JF, Tadmor T, Tallman MS, Tam C, Tiacci E, Troussard X, Zent CS, Zenz T, Zinzani PL, Falini B. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood. 2016 Nov 30. pii: blood-2016-01-689422.
  • Alvarnas JC, Le Rademacher J, Wang Y, Little RF, Akpek G, Ayala E, Devine S, Baiocchi R, Lozanski G, Kaplan L, Noy A, Popat U, Hsu J, Morris LE Jr, Thompson J, Horowitz MM, Mendizabal A, Levine A, Krishnan A, Forman SJ, Navarro WH, Ambinder R. Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial. Blood. 2016 Aug 25;128(8):1050-8.
  • Vasu S, Geyer S, Bingman A, Auletta JJ, Jaglowski S, Elder P, O'Donnell LC, Bradbury H, Kitzler R, Andritsos L, Blum W, Klisovic R, Penza S, Efebera Y, Hofmeister C, Benson DM, Muthusamy N, Lozanski G, Devine SM. Erratum to "Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease" [Biol Blood Marrow Transplant 22(2016):658-668]. Biol Blood Marrow Transplant. 2016 Jul;22(7):1341.
  • Vasu S, He S, Cheney C, Gopalakrishnan B, Mani R, Lozanski G, Mo X, Groh V, Whitman SP, Konopitzky R, Kössl C, Bucci D, Lucas DM, Yu J, Caligiuri MA, Blum W, Adam PJ, Borges E, Rueter B, Heider KH, Marcucci G, Muthusamy N. Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts. Blood. 2016 Jun 9;127(23):2879-89.
  • Alinari L, Gru A, Quinion C, Huang Y, Lozanski A, Lozanski G, Poston J, Venkataraman G, Oak E, Kreisel F, Park SI, Matthews S, Abramson JS, Iris Lim H, Martin P, Cohen JB, Evens A, Al-Mansour Z, Singavi A, Fenske TS, Blum KA. De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort. Am J Hematol. 2016 Jun;91(4):395-9.
  • Kroll KW, Eisfeld AK, Lozanski G, Bloomfield CD, Byrd JC, Blachly JS. MuCor: mutation aggregation and correlation. Bioinformatics. 2016 May 15;32(10):1557-8.
  • Vasu S, Geyer S, Bingman A, Auletta JJ, Jaglowski S, Elder P, Donnell LO, Bradbury H, Kitzler R, Andritsos L, Blum W, Klisovic R, Penza S, Efebera Y, Hofmeister C, Benson DM, Muthusamy N, Lozanski G**, Devine SM. Granulocyte Colony Stimulating Factor Mobilized Allografts Contain Immune Cell Subsets with Risk of Acute and Chronic Graft-Versus-Host Disease Biol Blood Marrow Transplant. 2015 Dec 29 (** Senior coauthor)
  • Fauzi MF, Pennell M, Sahiner B, Chen W, Shana'ah A, Hemminger J, Gru A, Kurt H, Losos M, Joehlin-Price A, Kavran C, Smith SM, Nowacki N, Mansor S, Lozanski G**, Gurcan MN. Classification of follicular lymphoma: the effect of computer aid on pathologist grading. BMC Med Inform Decision Making. 2015 Dec 30;15(1):115. (** Senior coauthor)
  • Rawstron AC, Fazi C, Agathangelidis A, Villamor N, Letestu R, Nomdedeu J, Palacio C, Stehlikova O, Kreuzer KA, Liptrot S, O'Brien D, de Tute RM, Marinov I, Hauwel M, Spacek M, Dobber J, Kater AP, Gambell P, Soosapilla A, Lozanski G, Brachtl G, Lin K, Boysen J, Hanson C, Jorgensen JL, Stetler-Stevenson M, Yuan C, Broome HE, Rassenti L, Craig F, Delgado J, Moreno C, Bosch F, Egle A, Doubek M, Pospisilova S, Mulligan S, Westerman D, Sanders CM, Emerson R, Robins HS, Kirsch I, Shanafelt T, Pettitt A, Kipps TJ, Wierda WG, Cymbalista F, Hallek M, Hillmen P, Montserrat E, Ghia P. A complimentary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative in CLL study Leukemia. 2015 Dec 7.
  • Balatti V, Rizzotto L, Miller C, Palamarchuk A, Fadda P, Pandolfo R, Rassenti LZ, Hertlein E, Ruppert AS, Lozanski A, Lozanski G, Kipps TJ, Byrd JC, Croce CM, Pekarsky Y. TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2015 Feb 2.
  • Rogers KA, Ruppert AS, Bingman A, Andritsos LA, Awan FT, Blum KA, Flynn JM, Jaglowski SM, Lozanski G, Maddocks KJ, Byrd JC, Woyach JA, Jones JA. Incidence and description of autoimmune cytopenias with ibrutininb for chronic lymphocytic leukemia Leukemia. 2016 Feb;30(2):346-50.
  • Tsai YT, Lozanski G, Lehman A, Sass EJ, Hertlein E, Salunke SB, Chen CS, Grever MR, Byrd JC, Lucas DM. BRAFV600E induces ABCBA/P-glycoprotein expression and drug resistance in B cells via AP-1 activation. Leuk Res. 2015 Sep 145-2126(15)30371-4.